logo

Aveo Pharmaceuticals, Inc. (AVEO)



Trade AVEO now with
  Date
  Headline
3/16/2020 4:15:32 PM AVEO Oncology Q4 Loss/share $0.28 Vs. Loss $0.35 Year Ago
2/19/2020 9:12:33 AM AVEO Oncology To Effect A 1-for-10 Reverse Stock Split
1/27/2020 7:12:58 AM AVEO, Biodesix Announce Results From Phase 1b Study In Advanced Pancreatic Cancer
1/6/2020 7:05:12 AM AVEO Oncology Appoints Erick Lucera As CFO
11/19/2019 7:06:21 AM AVEO Oncology Appoints Scarlett Spring To Its Board
11/18/2019 6:03:19 AM AVEO Presents Updated OS And Subgroup Data From Phase 3 TIVO-3 Trial Of Tivozanib In Renal Cell Carcinoma
11/12/2019 7:21:33 AM AVEO Oncology Q3 EPS $0.10 Vs Loss $0.18 Last Year
11/4/2019 7:25:31 AM AVEO Oncology Announces Regulatory Update For Tivozanib In Renal Cell Carcinoma
9/30/2019 7:06:12 AM AVEO Oncology Begins Enrollment In Phase 1b/2 Trial On FOTIVDA In Combination With IMFINZI
12/12/2018 7:11:03 AM AVEO Oncology Announces Immuno-Oncology Clinical Collaboration With AstraZeneca
11/9/2018 7:13:02 AM AVEO Oncology Q3 Net Loss $22.2 Mln Or $0.18/shr Vs. Net Loss $26.4 Mln Or $0.22/shr Last Year
10/22/2018 7:08:06 AM AVEO Oncology, EUSA Pharma Announce Updated Interim Results From Phase 2 Portion Of TiNivo Study
10/1/2018 7:14:49 AM AVEO Oncology Begins Topline Analysis Of Phase 3 TIVO-3 Trial
  
 
>